Clinical Trials Directory

Trials / Terminated

TerminatedNCT00023166

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
—
Sponsor
Enzon Pharmaceuticals, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Studies of PEG-paclitaxel have been terminated

Conditions

Interventions

TypeNameDescription
DRUGPEG-paclitaxel

Timeline

Start date
2001-05-01
Completion
2002-05-01
First posted
2001-08-27
Last updated
2005-06-24

Source: ClinicalTrials.gov record NCT00023166. Inclusion in this directory is not an endorsement.